GPCR NewsAug 1, 20221 minGPCR Industry NewsKaruna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...August 2022 Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia "BOSTON--(BUSINESS...
GPCR NewsApr 1, 20221 minGPCR Industry NewsModulation of Striatal Adenosinergic Function by HTL0041178, a Selective GPR52 AgonistApril 2022 "By Cliona MacSweeney | Apr 20, 2022 Cliona MacSweeney, a project director in our Translational Medicine department, recently...
GPCR NewsApr 1, 20221 minGPCR Industry NewsAddex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment ...April 2022 Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment Of Schizophrenia & Other...